23 results

• BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain

  May 14, 2025

  Irvin Jackson

  A Massachusetts woman's injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit.

• Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries

  May 5, 2025

  Irvin Jackson

  A multi-plaintiff product liability lawsuit accuses Hologic of knowingly marketing its defective, and now recalled BioZorb implant to breast cancer survivors.

• Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy

  April 14, 2025

  Irvin Jackson

  A BioZorb marker lawsuit filed by a North Carolina woman claims the breast implant failed to dissolve properly, requiring surgical removal.

• Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials

  April 2, 2025

  Irvin Jackson

  As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.

• Court Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker

  March 26, 2025

  Irvin Jackson

  A U.S. District Judge has rejected a motion to dismiss BioZorb design defect claims raised in a number of lawsuits, allowing the claims to move forward over painful complications experienced by women who received the breast tissue marker.

• Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker

  March 19, 2025

  Irvin Jackson

  A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic.

• Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker

  March 12, 2025

  Irvin Jackson

  A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications.

• BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker

  March 5, 2025

  Irvin Jackson

  A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker.

• Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court

  February 21, 2025

  Irvin Jackson

  A federal judge has issued pretrial schedules for the first two BioZorb lawsuits to go before juries starting in September, calling for the parties to outline all the issues of contention, witnesses and facts to be presented during the bellwether early test cases.

• Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases

  February 12, 2025

  Irvin Jackson

  A federal judge has rejected plaintiffs' request to reopen the discovery and deposition process in BioZorb lawsuits following last October's global recall of the tissue markers.